A recent study published in Annals of Oncology has concluded that a blood test purported to detect over 50 different types of cancer "is accurate enough to be rolled out as a multi-cancer screening test among people at higher risk of the disease, including patients aged 50 years or older, without symptoms." According to study first author, Dr. Eric Klein, chairman of the Glickman Urological and Kidney Institute in Cleveland, finding conducted on 15.254 participants from 142 clinics across North America, early detection of common cancers via a blood test is a viable option for communities with poor access to medical facilities,
To read more about this study, click here.
Study mentioned:
- “Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set”, by Eric Klein et al. Annals of Oncology. doi: https://doi.org/10.1016/j.annonc.2021.05.806
No comments:
Post a Comment